Yori Gidron1, Alain Ronson. 1. Brunel University, Uxbridge, Middlesex, UK bInstitute of Jules Bordet, The Free University of Brussels, Brussels, Belgium. Yori.Gidron@brunel.ac.uk
Abstract
PURPOSE OF REVIEW: The present article briefly reviews the prognostic role of psychosocial factors in cancer and concentrates on biological markers that may mediate such relationships. We focus on specific markers that show promising mediating roles. RECENT FINDINGS: The article reviews the prognostic role of psychosocial factors as shown in longitudinal studies and in previous reviews. We present the general stress response and its relevance to cancer progression. The main focus of the article is on the prognostic roles of specific biomarkers that had to meet three criteria for being accepted as biomarkers - being related to a psychosocial factor at the level of the brain, the circulation, and the tissue/cellular level. We review studies supporting the mediating roles of neurohormones and neurotransmitters (e.g., cortisol, norepinephrine), the vagal nerve and inflammation, interleukin-1, DNA damage, and the hormone oxytocin. SUMMARY: These biomarkers may mediate the relationships between certain psychosocial factors (e.g., hopelessness, social support) and cancer progression. Future studies should test the effects of altering such biomarkers on the prognosis of patients scoring high/low on their associated psychosocial factors. Clinical implications that need to be tested are provided.
PURPOSE OF REVIEW: The present article briefly reviews the prognostic role of psychosocial factors in cancer and concentrates on biological markers that may mediate such relationships. We focus on specific markers that show promising mediating roles. RECENT FINDINGS: The article reviews the prognostic role of psychosocial factors as shown in longitudinal studies and in previous reviews. We present the general stress response and its relevance to cancer progression. The main focus of the article is on the prognostic roles of specific biomarkers that had to meet three criteria for being accepted as biomarkers - being related to a psychosocial factor at the level of the brain, the circulation, and the tissue/cellular level. We review studies supporting the mediating roles of neurohormones and neurotransmitters (e.g., cortisol, norepinephrine), the vagal nerve and inflammation, interleukin-1, DNA damage, and the hormone oxytocin. SUMMARY: These biomarkers may mediate the relationships between certain psychosocial factors (e.g., hopelessness, social support) and cancer progression. Future studies should test the effects of altering such biomarkers on the prognosis of patients scoring high/low on their associated psychosocial factors. Clinical implications that need to be tested are provided.
Authors: Michael Wirth; James Burch; John Violanti; Cecil Burchfiel; Desta Fekedulegn; Michael Andrew; Hongmei Zhang; Diane B Miller; James R Hébert; John E Vena Journal: Chronobiol Int Date: 2011-05 Impact factor: 2.877
Authors: John M Violanti; Desta Fekedulegn; Ja Kook Gu; Penelope Allison; Anna Mnatsakanova; Cathy Tinney-Zara; Michael E Andrew Journal: Int Arch Occup Environ Health Date: 2018-03-07 Impact factor: 3.015
Authors: Janine Giese-Davis; Kate Collie; Kate M S Rancourt; Eric Neri; Helena C Kraemer; David Spiegel Journal: J Clin Oncol Date: 2010-12-13 Impact factor: 44.544
Authors: Janine Giese-Davis; Frank H Wilhelm; Rie Tamagawa; Oxana Palesh; Eric Neri; Craig Barr Taylor; Helena C Kraemer; David Spiegel Journal: Psychosom Med Date: 2015-05 Impact factor: 4.312
Authors: Michael Wirth; James Burch; John Violanti; Cecil Burchfiel; Desta Fekedulegn; Michael Andrew; Hongmei Zhang; Diane B Miller; Shawn D Youngstedt; James R Hébert; John E Vena Journal: Neuro Endocrinol Lett Date: 2013 Impact factor: 0.765
Authors: Hosanna Soler-Vilá; Robert Dubrow; Vivian I Franco; Andrea K Saathoff; Stanislav V Kasl; Beth A Jones Journal: Cancer Date: 2009-09-15 Impact factor: 6.860